CAS 2023788-19-2

GLP-1 and GIP are two endogenous hormones involved in the body's blood glucose control mechanism. Tirzepatide can activate GLP-1 receptors, reducing hunger and thus decreasing food and calorie intake; the drug can also activate GIP receptors to reduce food and calorie intake and increase energy expenditure.